<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public" slc-id="S1-KEN25445-20D-62-W2Y"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 S2341 IS: Ensuring Safe and Toxic-Free Foods Act of 2025</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2025-07-17</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>119th CONGRESS</congress><session>1st Session</session><legis-num>S. 2341</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20250717">July 17, 2025</action-date><action-desc><sponsor name-id="S369">Mr. Markey</sponsor> (for himself, <cosponsor name-id="S370">Mr. Booker</cosponsor>, <cosponsor name-id="S366">Ms. Warren</cosponsor>, and <cosponsor name-id="S341">Mr. Blumenthal</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To amend the Federal Food, Drug, and Cosmetic Act to impose requirements for substances generally recognized as safe, to require the Commissioner of Food and Drugs to reassess the safety of chemicals added to food, and for other purposes. </official-title></form><legis-body display-enacting-clause="yes-display-enacting-clause"><section section-type="section-one" id="S1"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Ensuring Safe and Toxic-Free Foods Act of 2025</short-title></quote>.</text></section><section id="id6d68479c1d23474b9b4820aac5c66f1c"><enum>2.</enum><header>Substances generally recognized as safe</header><subsection commented="no" display-inline="no-display-inline" id="idb11f95f390254c818822e4cd69a9dfe0"><enum>(a)</enum><header display-inline="yes-display-inline">In general</header><text display-inline="yes-display-inline">Chapter IV of the Federal Food, Drug, and Cosmetic Act is amended by inserting after section 409 (<external-xref legal-doc="usc" parsable-cite="usc/21/348">21 U.S.C. 348</external-xref>) the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="idc4bf9f09dea9451c995dd8e3f4fbb8e0"><section id="id4be01a0cad034d9595cfeabc8d3c6369"><enum>409A.</enum><header>Substances generally recognized as safe</header><subsection commented="no" display-inline="no-display-inline" id="id89b688e3fed24d599660caf336568377"><enum>(a)</enum><header>In general</header><text>Any substance the intended use of which results or may reasonably be expected to result, directly or indirectly, in its becoming a component or otherwise affecting the characteristics of any food (including any substance intended for use in producing, manufacturing, packing, processing, preparing, treating, packaging, transporting, or holding food; and including any source of radiation intended for any such use), shall, with respect to any particular use or intended use, be deemed to be unsafe for the purposes of the application of clause (2)(C) of section 402(a), unless—</text><paragraph commented="no" display-inline="no-display-inline" id="id25b7ab9deecd4822bdc20f75cdc17120"><enum>(1)</enum><text>such substance is a food additive in compliance with section 409; </text></paragraph><paragraph id="id99baec965fca4b529d04aad6d61dc94e" commented="no"><enum>(2)</enum><text>subject to subsection (e)(2), the manufacturer has submitted, prior to the date of enactment of the <short-title>Ensuring Safe and Toxic-Free Foods Act of 2025</short-title>, a notice to the Secretary that the manufacturer has concluded that such substance is generally recognized as safe under the conditions of its intended use, and the Secretary has not issued a response or has issued a response stating that the Secretary does not question the basis for such conclusion; or </text></paragraph><paragraph id="id267cea26d1314c42aec1f8d6815de5f7"><enum>(3)</enum><subparagraph commented="no" display-inline="yes-display-inline" id="id947fc6d7138c452d9a079adf0bb3e035"><enum>(A)</enum><text>the manufacturer has submitted, during the period beginning on the date of enactment of the <short-title>Ensuring Safe and Toxic-Free Foods Act of 2025</short-title> and ending on the day before the effective date described in section 2(d) of such Act, a notice to the Secretary that the manufacturer has determined such substance to be generally recognized as safe under the conditions of its intended use; </text></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ida635e731a5dc4730ab661e54d03252ae" indent="up1"><enum>(B)</enum><text display-inline="yes-display-inline">such notice includes supporting information sufficient to justify the basis of such determination, including full reports of investigations made with respect to the safety for use of such substance, including—</text><clause commented="no" display-inline="no-display-inline" id="idb7dd40926fd144af92e5dc75ff54049a"><enum>(i)</enum><text display-inline="yes-display-inline">full information as to the methods and controls used in conducting such investigations;</text></clause><clause commented="no" display-inline="no-display-inline" id="idb8aff367f7d048b7b52de6810e3272c0"><enum>(ii)</enum><text display-inline="yes-display-inline">information on the cumulative effects of such substance; </text></clause><clause commented="no" display-inline="no-display-inline" id="id853aadf5645747eb9b02740c838352f1"><enum>(iii)</enum><text display-inline="yes-display-inline">information on hazard, dose response, and exposure;</text></clause><clause commented="no" display-inline="no-display-inline" id="id8e5a5db8892b48dba109e95efdf9381f"><enum>(iv)</enum><text display-inline="yes-display-inline">application of adequately protective safety factors to ensure an appropriate margin of safety to take into account uncertainties in hazard identification, dose response, exposure, and sensitivities;</text></clause><clause commented="no" display-inline="no-display-inline" id="idcc52dc1955bf4729b78b1fca8324b1f2"><enum>(v)</enum><text display-inline="yes-display-inline">information demonstrating that the weight of the evidence analysis shows that such substance has not been found to be carcinogenic; and</text></clause><clause commented="no" display-inline="no-display-inline" id="id0d278a9fe8cf4d87b78f97d0f0bf3a70"><enum>(vi)</enum><text display-inline="yes-display-inline">information demonstrating that the weight of the evidence analysis shows that such substance has not been found to induce reproductive toxicity or developmental toxicity in humans or animals, including through an endocrine mode of action; and </text></clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" indent="up1" id="id903ca164c73349bc99c9ed82b05da3d0"><enum>(C)</enum><text display-inline="yes-display-inline">the Secretary has not objected to such determination under subsection (c).</text></subparagraph></paragraph></subsection><subsection id="id5959cac6a1c14f5bad33fea3014f81ee"><enum>(b)</enum><header>Public availability and comment</header><text display-inline="yes-display-inline">On receipt of a notice of a determination described in subsection (a)(3)(A), the Secretary shall—</text><paragraph commented="no" display-inline="no-display-inline" id="id45df6710af6840df87bc7b933f480ebc"><enum>(1)</enum><text display-inline="yes-display-inline">make such notice and the supporting information included with such notice publicly available on the website of the Food and Drug Administration; and</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="id0e828bf9420e4cc48386bff31ffb9ed1"><enum>(2)</enum><text display-inline="yes-display-inline">provide an opportunity for public comment for a period of not less than 60 days.</text></paragraph></subsection><subsection id="id9327e44728c94ac8a7de26610a6f377e"><enum>(c)</enum><header>Determination of Secretary</header><paragraph id="ida95f33fb5b2d4be7a1eb5fe283f6b23d"><enum>(1)</enum><header>In general</header><text>The Secretary shall issue a written statement objecting to a determination described in subsection (a)(3)(A) if 1 or more of the criteria described in paragraph (2) are not met.</text></paragraph><paragraph id="ide2b288e072d04b1fa813c0a2ae9a9251"><enum>(2)</enum><header>Criteria</header><text>The criteria described in this paragraph are the following: </text><subparagraph id="idbbc3fc7935ac4e64961577ba30203486"><enum>(A)</enum><text>The manufacturer has submitted complete documentation justifying the basis for its determination as described in subsection (a)(3)(B).</text></subparagraph><subparagraph id="id9639a5169fbf4f7a87aeae97fa86e038" commented="no"><enum>(B)</enum><text>With respect to data used for such justification that was provided by an expert, such expert does not have a conflict of interest.</text></subparagraph><subparagraph id="idb2b5606dd36c4a33881cb729355fbd2d"><enum>(C)</enum><text>The available evidence adequately supports a determination that the substance is generally recognized as safe under the conditions of its intended use.</text></subparagraph></paragraph><paragraph id="idc9933547a3934dbb87c0f006659e2ab2"><enum>(3)</enum><header>Determination not to object</header><text>With respect to a determination described in subsection (a)(3)(A), if the Secretary determines that all of the criteria described in paragraph (2) are met, the Secretary shall issue a written statement that the Secretary is not objecting to such determination described in subsection (a)(3)(A).</text></paragraph><paragraph id="id9b8ae22f950441ffa238e29cd554ac0c"><enum>(4)</enum><header>Additional information</header><text>Before objecting to a determination described in subsection (a)(3)(A), the Secretary may request additional information from the manufacturer if the Secretary determines the manufacturer has failed to submit complete documentation justifying the basis for its determination as described in subsection (a)(3)(B).</text></paragraph><paragraph id="id13ab266dd01b4a318418107dd8fd86d8" commented="no"><enum>(5)</enum><header>Final agency action</header><text>The determination of the Secretary to object or not to object under this subsection to a determination described in subsection (a)(3)(A) shall be considered to be a final agency action.</text></paragraph><paragraph id="idf31b66f085df4daab224329dc0583f58"><enum>(6)</enum><header>Publication</header><text>The Secretary shall publish the basis of a determination to object or to not object under this subsection to a determination described in subsection (a)(3)(A) on the website of the Food and Drug Administration, including any chemistry and toxicology memoranda produced or relied on by the Secretary in making such determination. Failure to publish such a determination shall not be construed as an affirmative finding by the Secretary that the substance is generally recognized as safe.</text></paragraph><paragraph id="id137cae5bb00e47b081b771ae97418db6"><enum>(7)</enum><header>Definition of conflict of interest</header><text>In this subsection, the term <term>conflict of interest</term> means a financial interest that could potentially compromise the professional judgment or objectivity of an individual in designing, conducting, reporting, or reviewing research or the applicability of research, potentially undermining the integrity of such research.</text></paragraph></subsection><subsection id="id3b6c4914af044c548beafacc4bd65e98"><enum>(d)</enum><header>Standards for experts evaluating whether a substance is GRAS</header><text display-inline="yes-display-inline">Not later than 180 days after the date of enactment of the <short-title>Ensuring Safe and Toxic-Free Foods Act of 2025</short-title>, the Secretary shall issue guidance to strengthen the recommendations contained in the December 2022 guidance of the Food and Drug Administration entitled <quote>Best Practices for Convening a GRAS Panel</quote>.</text></subsection><subsection id="id626c3e67b3d045a39d994f1de8ccb0cd" commented="no"><enum>(e)</enum><header>Reassessment</header><paragraph commented="no" display-inline="no-display-inline" id="id0ab66f8ca07d4b68be93794409f183f1"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">With respect to a substance for which the Secretary has determined under subsection (c)(3) not to object to the manufacturer's determination under subsection (a)(3)(A) that such substance is generally recognized as safe under the conditions of its intended use, the Secretary may, at any time—</text><subparagraph commented="no" display-inline="no-display-inline" id="ide9e3cd02ed2b4bb08b6ed94bd11d20ab"><enum>(A)</enum><text display-inline="yes-display-inline">reassess in accordance with subsection (c) whether such substance is generally recognized as safe under the conditions of its intended use; and </text></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id703f73d7da204cd29fc6eea8acafc9f9"><enum>(B)</enum><text display-inline="yes-display-inline">pursuant to such reassessment, withdraw the determination of the Secretary not to object under subsection (c)(3).</text></subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="id63e2c77603aa4dbda35dec9019311bd6"><enum>(2)</enum><header>Prior submissions to GRAS notification program</header><text>The Secretary may require the manufacturer of a substance described in subsection (a)(2) to submit a notice for such substance that includes the information described in subsection (a)(3). The Secretary shall review such notice in accordance with subsections (b) and (c). </text></paragraph></subsection><subsection id="id4a1ed975fbf640b5b758955a639f5555"><enum>(f)</enum><header>Timeline for review of GRAS submissions</header><paragraph commented="no" display-inline="no-display-inline" id="idca230dd69bf146188f33862240cef07f"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary shall review not fewer than 50 notices described in paragraphs (2) and (3) of subsection (a) each year until all such notices have been reviewed.</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="id86ad019b9bee4277ba8df34cf542d667"><enum>(2)</enum><header>Requirements</header><text>In conducting a review described in paragraph (1), the Secretary shall—</text><subparagraph commented="no" display-inline="no-display-inline" id="idacadbc0f48b0431fb105d07b7cfd53df"><enum>(A)</enum><text display-inline="yes-display-inline">with respect to a noticed described in subsection (a)(2), issue a response to such notice stating that, as applicable—</text><clause commented="no" display-inline="no-display-inline" id="id36eac6727f6249d58fcce7f5eeeba054"><enum>(i)</enum><text display-inline="yes-display-inline">the Secretary does not question the basis for such conclusion; or</text></clause><clause commented="no" display-inline="no-display-inline" id="id10f0f757ca364eb7b1a0240a3a7d2dac"><enum>(ii)</enum><text>the Secretary has concluded that such notice does not provide a sufficient basis for such conclusion; and</text></clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id76ed70d2cfed4aaa9650d13d0ca0e0ee"><enum>(B)</enum><text>with respect to a notice described in subsection (a)(3), issue a response in accordance with, as applicable, paragraph (1) or (3) of subsection (c). </text></subparagraph></paragraph></subsection><subsection id="id09452b065af64593827541af3acf1129"><enum>(g)</enum><header>Definitions</header><text>In this section:</text><paragraph commented="no" display-inline="no-display-inline" id="id6e1472c86fac441baab60c00e6e8eca8"><enum>(1)</enum><header>Carcinogenic</header><subparagraph commented="no" display-inline="no-display-inline" id="id3fd329f199d34fbda97c0c512c376818"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">The term <term>carcinogenic</term>, with respect to a substance, means such substance is found to induce cancer when ingested by humans or animals, or is found, after tests that are appropriate for the evaluation of the safety of substances, to induce cancer in humans or animals.</text></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id7a06e05b03074dd8bd4116825f83a013"><enum>(B)</enum><header>Requirement</header><text display-inline="yes-display-inline">In determining whether a substance is carcinogenic for purposes of subparagraph (A), the Secretary shall consider assessments conducted by authoritative bodies, including the National Toxicology Program, the International Agency for Research on Cancer, and the Environmental Protection Agency.</text></subparagraph></paragraph><paragraph id="id068f33499e964cbb9ee8c61b3f2d1c93"><enum>(2)</enum><header>Cumulative effects</header><text>The term <term>cumulative effects</term>, with respect to a substance, means the combined health effects of all chemically or pharmacologically related substances.</text></paragraph><paragraph id="idfb27326bf88d4bd59f14524e8db12453"><enum>(3)</enum><header>Developmental toxicity</header><text>The term <term>developmental toxicity</term>, with respect to the effect of exposure to a substance on a human or animal, means an adverse effect on the development of such human or animal that results from such exposure—</text><subparagraph commented="no" display-inline="no-display-inline" id="idc42c8c217f8947478c3fa49deb2ae6b5"><enum>(A)</enum><text display-inline="yes-display-inline">to the mother prior to conception of, or during the prenatal period for, such human or animal; or </text></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="idc7466a456b0b461da0319e745e757fa5"><enum>(B)</enum><text display-inline="yes-display-inline">to such human or animal before the time of sexual maturity.</text></subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="id08ba522cf0b44525941a10caa5e57ccd"><enum>(4)</enum><header>Generally recognized as safe</header><subparagraph commented="no" display-inline="no-display-inline" id="id7538a4b09d554eeeaf8be71e2d884970"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">The term <term>generally recognized as safe</term>, with respect to a substance, means such substance is generally recognized, among experts qualified by scientific training and experience to evaluate its safety, as having been adequately shown through scientific procedures (or, in the case of a substance used in food prior to January 1, 1958, through either scientific procedures or experience based on common use in food) to be safe under the conditions of its intended use.</text></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id2216457adea94cd5aefb2b19f1f530db"><enum>(B)</enum><header>Exclusions</header><text>The term <term>generally recognized as safe</term>, with respect to a substance, does not include a substance that—</text><clause commented="no" display-inline="no-display-inline" id="id8db2836406b74722abac571bd9a86881"><enum>(i)</enum><text display-inline="yes-display-inline">is carcinogenic;</text></clause><clause commented="no" display-inline="no-display-inline" id="idb4cb4184e8e04547bc6d0daef1a61906"><enum>(ii)</enum><text display-inline="yes-display-inline">shows evidence of reproductive toxicity or developmental toxicity;</text></clause><clause commented="no" display-inline="no-display-inline" id="idcaedfc694b7d491298f630a021c250da"><enum>(iii)</enum><text display-inline="yes-display-inline">is otherwise identified as toxic by the National Toxicology Program, the Environmental Protection Agency, the Agency for Toxic Substances and Disease Registry, or the California Office of Environmental Health Hazard Assessment; </text></clause><clause commented="no" display-inline="no-display-inline" id="id7b00d3fd56cf4794b37238ee04b3c27f"><enum>(iv)</enum><text display-inline="yes-display-inline">was not marketed for use in foods in the United States prior to the date of enactment of the <short-title>Ensuring Safe and Toxic-Free Foods Act of 2025</short-title>; or </text></clause><clause commented="no" display-inline="no-display-inline" id="idfe8f10af1e6d40f1987b71dc148a5b0f"><enum>(v)</enum><text display-inline="yes-display-inline">was not synthesized, characterized, or isolated prior to the date of enactment of the <short-title>Ensuring Safe and Toxic-Free Foods Act of 2025</short-title>. </text></clause></subparagraph></paragraph><paragraph id="idcef1e1230dfb41539c5232cd9fa0acd9"><enum>(5)</enum><header>Reproductive toxicity</header><text>The term <term>reproductive toxicity</term>, with respect to the effect of exposure to a substance on a human or animal, means an adverse effect on the reproductive system of such human or animal, which may include alterations to reproductive system development, the endocrine system, fertility, pregnancy, pregnancy outcomes, or modifications in other functions that are dependent on the integrity of the reproductive system.</text></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="id17d34033a37c4d24ba2a375ac7e709ca"><enum>(h)</enum><header>Authorization of appropriations</header><text display-inline="yes-display-inline">There are authorized to be appropriated to carry out this section such sums as are necessary.</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection commented="no" display-inline="no-display-inline" id="id679d5ebaa2914b0d96eae49dc40987fe"><enum>(b)</enum><header>Adulteration</header><text>Section 402(a)(2)(C)(i) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/342">21 U.S.C. 342(a)(2)(C)(i)</external-xref>) is amended by inserting <quote>or any other substance that is not generally recognized as safe in compliance with section 409A</quote> after <quote>section 409</quote>.</text></subsection><subsection id="ide7b29fd0c47748d7878d96e35f8b6e4b"><enum>(c)</enum><header>Definitions</header><text>Section 201(s) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321(s)</external-xref>) is amended—</text><paragraph id="idce771b725c064822aa4b339934d212eb"><enum>(1)</enum><text>by striking <quote>if such substance is not generally recognized, among experts qualified by scientific training and experience to evaluate its safety, as having been adequately shown through scientific procedures (or, in the case of a substance used in food prior to January 1, 1958, through either scientific procedures or experience based on common use in food) to be safe under the conditions of its intended use;</quote>; </text></paragraph><paragraph id="idde43c64fceb0465cb6253ffc2ccbca9a"><enum>(2)</enum><text>in paragraph (5), by striking <quote>or</quote> at the end;</text></paragraph><paragraph id="idcd72979f952d4854969b5317d66e7c82"><enum>(3)</enum><text>in paragraph (6), by striking the period and inserting <quote>; or</quote>; and</text></paragraph><paragraph id="idffd7522fa5994bcfb76362e2c364d6ef"><enum>(4)</enum><text>by adding at the end the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="idfed5e782888642a8a7b267af87645913"><paragraph id="idb66a242810ea40cb88381bf2b7a8746f"><enum>(7)</enum><text>a substance generally recognized as safe in compliance with section 409A.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="id09a222b432dd4a199989b736bd89b944"><enum>(d)</enum><header>Effective date</header><text>The amendments made by this section shall take effect on the date that is 2 years after the date of enactment of this Act. </text></subsection></section><section id="id28fa944bde6c4ab2acaa81518742dae3"><enum>3.</enum><header>Food chemical reassessment</header><text display-inline="no-display-inline">Chapter IV of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/341">21 U.S.C. 341 et seq.</external-xref>) is amended by inserting after section 409A (as added by section 2(a)) the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="id35de5843dc354796ae56e9d0573bd768"><section id="id8bc6173c6bab4b46a2aab2e6c890259d"><enum>409B.</enum><header>Food chemical reassessment</header><subsection id="id796ee5d7cc7f4cb7b36f10a083033d21"><enum>(a)</enum><header>Safety reassessments</header><paragraph commented="no" display-inline="no-display-inline" id="idf41bb0754099497799751066aaaff906"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Not later than 3 years after the date of enactment of this section, and not less frequently than once every 3 years thereafter, the Secretary shall reassess the safety, within the meaning of section 409 or section 409A, of not less than 10 substances or classes of substances—</text><subparagraph id="idfcf6762d3f1d4c26ac40aab982a6ac48"><enum>(A)</enum><text>to determine if such substance or class of substances is safe within the meaning of section 409 or section 409A; and </text></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="idc00114487f2b48f787ba7aee4d861a8f"><enum>(B)</enum><text display-inline="yes-display-inline">to establish the conditions of use, if any, under which any such substance or class of substances may be used safely within the meaning of such section 409 or 409A.</text></subparagraph></paragraph><paragraph id="idb5995ae96238412ab16e42dae201d876"><enum>(2)</enum><header>Requirements for manufacturers</header><text>The Secretary may require any manufacturer of a substance or class of substances that is being reassessed under paragraph (1) to provide data or to conduct evaluations of such substance or class of substances for purposes of the reassessment under paragraph (1).</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="id60b1f766ab684461a79f6d10dd9c165c"><enum>(3)</enum><header>Priority</header><text>The Secretary may give priority to the reassessment of a substance or class of substances that is the subject of—</text><subparagraph commented="no" display-inline="no-display-inline" id="idb053b9d256e24c85a70fb34eaca4bff3"><enum>(A)</enum><text display-inline="yes-display-inline">a food additive petition under section 409(b); </text></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id5b8486ab45604486ac565e74e106becf"><enum>(B)</enum><text display-inline="yes-display-inline">a color additive petition under section 721(d); or </text></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id4a06cf57d82745268fa0b600797c22ec"><enum>(C)</enum><text display-inline="yes-display-inline">a citizen petition to request the reassessment, restriction, or revocation of an existing authorization of such substance or class of substances.</text></subparagraph></paragraph></subsection><subsection id="id291be40dadd14c72808da351e63672b6"><enum>(b)</enum><header>Considerations</header><text>In determining, for the purposes of this section, whether a substance or class of substances is unsafe within the meaning of section 409 or section 409A, the Secretary shall consider the information described in clauses (i) through (vi) of section 409A(a)(3)(B).</text></subsection><subsection id="idb3658bee7d2049bb84f081f7081f094e"><enum>(c)</enum><header>Rule of construction</header><text>Nothing in this section alters the authority or duties of the Secretary with respect to the administration and enforcement of section 409 or section 409A.</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></section></legis-body></bill> 

